PT  - JOURNAL ARTICLE
AU  - Mellan, Thomas A
AU  - Hoeltgebaum, Henrique H
AU  - Mishra, Swapnil
AU  - Whittaker, Charlie
AU  - Schnekenberg, Ricardo P
AU  - Gandy, Axel
AU  - Unwin, H Juliette T
AU  - Vollmer, Michaela A C
AU  - Coupland, Helen
AU  - Hawryluk, Iwona
AU  - Faria, Nuno Rodrigues
AU  - Vesga, Juan
AU  - Zhu, Harrison
AU  - Hutchinson, Michael
AU  - Ratmann, Oliver
AU  - Monod, Mélodie
AU  - Ainslie, Kylie E C
AU  - Baguelin, Marc
AU  - Bhatia, Sangeeta
AU  - Boonyasiri, Adhiratha
AU  - Brazeau, Nicholas
AU  - Charles, Giovanni
AU  - Cucunuba, Zulma
AU  - Cuomo-Dannenburg, Gina
AU  - Dighe, Amy
AU  - Eaton, Jeff
AU  - Elsland, Sabine L van
AU  - Gaythorpe, Katy A M
AU  - Green, Will
AU  - Knock, Edward
AU  - Laydon, Daniel
AU  - Lees, John A
AU  - Mousa, Andria
AU  - Nedjati-Gilani, Gemma
AU  - Nouvellet, Pierre
AU  - Parag, Kris V
AU  - Thompson, Hayley A
AU  - Verity, Robert
AU  - Walters, Caroline E
AU  - Wang, Haowei
AU  - Wang, Yuanrong
AU  - Watson, Oliver J
AU  - Whittles, Lilith
AU  - Xi, Xiaoyue
AU  - Dorigatti, Ilaria
AU  - Walker, Patrick
AU  - Ghani, Azra C
AU  - Riley, Steven
AU  - Ferguson, Neil M
AU  - Donnelly, Christl A
AU  - Flaxman, Seth
AU  - Bhatt, Samir
TI  - Subnational analysis of the COVID-19 epidemic in Brazil
AID  - 10.1101/2020.05.09.20096701
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.09.20096701
4099  - http://medrxiv.org/content/early/2020/08/24/2020.05.09.20096701.short
4100  - http://medrxiv.org/content/early/2020/08/24/2020.05.09.20096701.full
AB  - Brazil is currently reporting the second highest number of COVID-19 deaths in the world. Here we characterise the initial dynamics of COVID-19 across the country and assess the impact of non-pharmaceutical interventions (NPIs) that were implemented using a semi-mechanistic Bayesian hierarchical modelling approach. Our results highlight the significant impact these NPIs had across states, reducing an average Rt > 3 to an average of 1.5 by 9-May-2020, but that these interventions failed to reduce Rt < 1, congruent with the worsening epidemic Brazil has experienced since. We identify extensive heterogeneity in the epidemic trajectory across Brazil, with the estimated number of days to reach 0.1% of the state population infected since the first nationally recorded case ranging from 20 days in São Paulo compared to 60 days in Goiás, underscoring the importance of sub-national analyses in understanding asynchronous state-level epidemics underlying the national spread and burden of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work used the Cirrus UK National Tier-2 HPC Service at EPCC (http://www.cirrus.ac.uk) funded by the University of Edinburgh and EPSRC (EP/P020267/1). We would like to thank Amazon AWS and Microsoft Azure for computational credits. We would like to thank the Stan Development team for their constant support. We acknowledge the Medical Research Council and FAPESP (MR/S0195/1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is based on data available in the public domain.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code used is publicly available. https://covid.saude.gov.br/ https://www.ibge.gov.br/ https://github.com/ImperialCollegeLondon/covid19model